Multilevel Factors Predict Medication Adherence and Efficacy within 12 Months in Patients Receiving PCSK9 Monoclonal Antibodies: The Findings from a Real-World Analysis in China
A better education and LDL-C ＜1.4 mmol/L at 3 months after starting treatment with PCSK9-mAbs were consistent predictors of adherence. In addition, the treatment effect declined more significantly in the poor adherence group over time.
Authors
- Xiaomeng Zheng
- Hanbin Cui (ORCID: https://orcid.org/0000-0002-0835-1134)
- Yiyi Jin (ORCID: https://orcid.org/0000-0003-2984-1914)
- Suyan Zhu (ORCID: https://orcid.org/0009-0001-3920-185X)
- Miao Fan (ORCID: https://orcid.org/0000-0002-6675-1195)
Institutions
- Ningbo University (CN)
- Ningbo University Affiliated Hospital (CN)
- Ningbo First Hospital (CN)
Publication Details
- Journal
- Journal of Atherosclerosis and Thrombosis
- Published
- 2025-04-04
- DOI
- https://doi.org/10.5551/jat.65624
- Citations
- 1
- Primary Topic
- Pharmaceutical Economics and Policy
- Type
- article
- Field-Weighted Citation Impact
- 3.13
Funders
- Zhejiang Pharmaceutical Association
- Medical Science and Technology Project of Zhejiang Province
- Science and Technology Program of Zhejiang Province